At a Glance

NovoBliss Research® is a leading premier Contract Research Organization (CRO) headquartered in Ahmedabad, India, and registered with the Central Drugs Standard Control Organization (CDSCO). Certified under ISO 9001:2015, we are committed to advancing global clinical research through advancing Innovation, scientific rigor, ethical integrity, and operational excellence.

Established through the first-generation entrepreneurial vision of Dr. Nayan Patel (General Physician) and Dr. Maheshvari Patel (PhD, Pharmacology), NovoBliss Research® leverages over 40 years of combined global expertise spanning pharmaceuticals, dermatology, nutraceuticals, cosmetics, herbal and ayurvedic products, personal healthcare, and medical devices. This unique blend of clinical insight and scientific depth enables us to design research strategies that are both innovative and regulatory-compliant, ensuring credibility at every stage. Our leadership’s credibility is further reinforced by active participation in professional and ethical research bodies.

We are proud members of the Advertising Standards Council of India (ASCI) and the Indian Society for Clinical Research (ISCR). The empanelment of Dr. Maheshvari Patel as an Ex-Expert in Dermatology with ASCI further underscores our unwavering commitment to ethical practices, scientific accountability, and responsible research conduct.

Our state-of-the-art 12,000 sq. ft. facility is designed to meet stringent international standards and is supported by validated methods, robust SOPs, and transparent audit trails. Every process is aligned with Good Clinical Practice (GCP), ICH, and ISO standards, ensuring traceability, reproducibility, and regulatory acceptance across geographies.

NovoBliss Research® offers end-to-end research solutions, spanning early discovery to late-phase clinical validation.

  • Clinical Research & Trials (Phase I–IV)

    across pharmaceuticals, nutraceuticals, and personal healthcare products.

  • In-vitro, In-vivo, and Ex-vivo Studies

    for mechanistic insights and product characterization.

  • Real World Evidence (RWE) Research,

    including retrospective analyses, post-marketing surveillance, epidemiological studies, and prospective interventional trials.

  • Claims Substantiation Studies

    to support consumer healthcare, cosmetics, dermatology, OTC, herbal, and ayurvedic products in compliance with country-specific regulations.

  • Advanced Laboratory Testing

    for product safety, efficacy, and regulatory submissions.

We collaborate with global and domestic brands across a wide spectrum of industries:

  • Pharmaceuticals & Biopharmaceuticals

  • Nutraceuticals & Dietary Supplements

  • Dermatology & Cosmetic Science

  • Herbal & Ayurvedic Products

  • Medical Devices

  • Oral Care, Personal Care, and OTC Products

We specialize in claims substantiation and safety testing for consumer healthcare products, supported by advanced laboratory testing and comprehensive regulatory support to ensure product label claims are scientifically validated and globally compliant.

Our strength lies not only in capabilities but in execution excellence. Every protocol we design, every assay we perform, and every dataset we generate is guided by:

  • Evidence-based research methodologies"

  • Ethical and regulatory compliance"

  • Operational efficiency with global scalability"

  • Collaborative partnerships with leading academic institutions, hospitals, and industry players"

At NovoBliss Research®, science is not just methodology—it is a promise. A promise that every insight we deliver is credible, validated, and actionable. We position ourselves not merely as a service provider, but as a strategic partner, transforming innovation into safe, effective, and trusted products that meet regulatory demands, substantiate consumer claims, and inspire confidence worldwide.